New shot may slash cholesterol right after a heart attack

NCT ID NCT07102628

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether starting inclisiran early during a hospital stay for a heart attack can lower bad cholesterol more than a placebo, when both are added to standard care. About 300 adults hospitalized for a heart attack will receive either inclisiran or a placebo shot at the start and again 90 days later. The main goal is to see if inclisiran leads to greater cholesterol reduction by day 150.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Inclisiran

What this could lead to

If it works, this could provide a new way to quickly lower bad cholesterol after a heart attack, potentially reducing the risk of future heart problems.

What could go wrong

This is still an early Phase 3 trial with 300 participants, so results may not apply to everyone. Inclisiran may not lower cholesterol enough or could have side effects not yet seen.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome hyperlipidemia Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Novartis Investigative Site

    RECRUITING

    Kiel, 24105, Germany

  • Novartis Investigative Site

    RECRUITING

    Hong Kong, Hong Kong, 999077, Hong Kong

  • Novartis Investigative Site

    RECRUITING

    Hong Kong, 999077, Hong Kong

  • Novartis Investigative Site

    RECRUITING

    Pécs, Baranya, 7623, Hungary

  • Novartis Investigative Site

    RECRUITING

    Debrecen, Hajdu Bihar Megye, 4032, Hungary

  • Novartis Investigative Site

    RECRUITING

    Budapest, 1134, Hungary

  • Novartis Investigative Site

    RECRUITING

    Budapest, H-1083, Hungary

  • Novartis Investigative Site

    RECRUITING

    Miskolc, 3526, Hungary

  • Novartis Investigative Site

    RECRUITING

    Belagavi, Karnataka, 590010, India

  • Novartis Investigative Site

    RECRUITING

    Mumbai, Maharashtra, 400012, India

  • Novartis Investigative Site

    RECRUITING

    Nashik, Maharashtra, 422005, India

  • Novartis Investigative Site

    RECRUITING

    Bikaner, Rajasthan, 334003, India

  • Novartis Investigative Site

    COMPLETED

    Chikushino-shi, Fukuka, 818-8516, Japan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kitakyushu, Fukuoka, 8028555, Japan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kamakura, Kanagawa, 247-8533, Japan

  • Novartis Investigative Site

    WITHDRAWN

    Sagamihara, Kanagawa, 252-0375, Japan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bunkyo Ku, Tokyo, 1138431, Japan

  • Novartis Investigative Site

    RECRUITING

    Gdansk, 80-214, Poland

  • Novartis Investigative Site

    RECRUITING

    Katowice, 40-635, Poland

  • Novartis Investigative Site

    RECRUITING

    Krakow, 31 202, Poland

  • Novartis Investigative Site

    RECRUITING

    Opole, 45-401, Poland

  • Novartis Investigative Site

    RECRUITING

    Seoul, Seoul, 06351, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 07804, South Korea

  • Novartis Investigative Site

    RECRUITING

    Santiago Compostela, A Coruna, 15706, Spain

  • Novartis Investigative Site

    RECRUITING

    Huelva, Andalusia, 21005, Spain

  • Novartis Investigative Site

    RECRUITING

    El Palmar, Murcia, 30120, Spain

  • Novartis Investigative Site

    RECRUITING

    Las Palmas GC, 35010, Spain

  • Novartis Investigative Site

    RECRUITING

    Madrid, 28034, Spain

  • Novartis Investigative Site

    RECRUITING

    Madrid, 28046, Spain

  • Novartis Investigative Site

    RECRUITING

    Salamanca, 37007, Spain

  • Novartis Investigative Site

    RECRUITING

    Seville, 41013, Spain

  • Novartis Investigative Site

    RECRUITING

    Valencia, 46010, Spain

  • Novartis Investigative Site

    RECRUITING

    Bern, 3010, Switzerland

  • Novartis Investigative Site

    RECRUITING

    Geneva, 1211, Switzerland

  • Novartis Investigative Site

    RECRUITING

    Lucerne, 6000, Switzerland

  • Novartis Investigative Site

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H1T 1C8, Canada

  • Novartis Investigative Site

    RECRUITING

    Québec, Quebec, G1V 4G5, Canada

  • Novartis Investigative Site

    RECRUITING

    Beijing, China, 100037, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Novartis Investigative Site

    RECRUITING

    Luoyang, Henan, 471002, China

  • Novartis Investigative Site

    RECRUITING

    Xuzhou, Jiangsu, 221003, China

  • Novartis Investigative Site

    RECRUITING

    Nanchang, Jiangxi, 330009, China

  • Novartis Investigative Site

    RECRUITING

    Wenzhou, Zhejiang, 325000, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100191, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100730, China

  • Novartis Investigative Site

    RECRUITING

    Fuzhou, 350001, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, 510260, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, 510280, China

  • Novartis Investigative Site

    RECRUITING

    Jining, 272011, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200032, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200120, China

  • Novartis Investigative Site

    RECRUITING

    Tianjin, 300052, China

  • Novartis Investigative Site

    RECRUITING

    Chambray-lès-Tours, 37170, France

  • Novartis Investigative Site

    RECRUITING

    Montpellier, 34295, France

  • Novartis Investigative Site

    RECRUITING

    Nantes, 44093, France

  • Novartis Investigative Site

    RECRUITING

    Pessac, 33604, France

  • Novartis Investigative Site

    RECRUITING

    Poitiers, 86021, France

  • Novartis Investigative Site

    RECRUITING

    Leipzig, Saxony, 04289, Germany

  • Novartis Investigative Site

    RECRUITING

    Coburg, 96450, Germany

  • Novartis Investigative Site

    RECRUITING

    Erfurt, 99089, Germany

  • Novartis Investigative Site

    RECRUITING

    Essen, 45147, Germany

  • Novartis Investigative Site

    RECRUITING

    Hennigsdorf, 16761, Germany